News & Activities
Epidermia launches ‘It’s Time for GPP’ in 4 languages! EuroPso members are invited to cooperate!
The EuroPso member for Greece, ‘Epdermia’ has just launched a 4- language version of their successful project in Greek called ‘It’s Time for GPP’.
European Psoriasis Week 2025: Advancing Equity in Psoriasis Care Across Europe
This year, the European Psoriasis Week shines a spotlight on equity — the cornerstone of quality healthcare. Under the banner #EPW2025, EUROPSO, the European Federation of Psoriasis Associations, is calling for urgent and coordinated action to ensure equal access to diagnosis, treatment, and long-term care for all individuals living with psoriasis across Europe.
EUROPSO Members Meeting Highlights – November 2024, Frankfurt
The EUROPSO Members Meeting, held on November 16, 2024, in Frankfurt,…
EUROPSO appointed as a member of the Health Technology Assessment Stakeholder Network
EUROPSO, the European umbrella organization representing national…
World Psoriasis Day 2024: Bridging the gaps in psoriatic disease treatment for families worldwide
Every year on October 29th, the world recognizes World Psoriasis…
Tackling gaps in psoriasis care: An imperative for the EU
This article was first published on Euractiv.com
Access to…
Access to…
‘It’s Time for GPP’ – new project by Epidermia for GPP patients
In July 2024, Epidermia, Greece, launched a website entitled…
Report on European Psoriasis Week 2024
Complete access to treatment across Europe: EUROPSO calls for…
Complete Access to Treatment Across Europe: EUROPSO Calls for Addressing Inequities in Psoriasis Healthcare
Brussels, May 29, 2024 – EUROPSO, the European Federation…
Complete Access to Treatment Across Europe: EUROPSO Urges Action on Psoriasis Healthcare Disparities
Brussels, May 27, 2024 - As European Psoriasis Week starts today,…
Our family’s fight against a mysterious skin disease- my father’s GPP story
Author: Tina Kasap
Going through a rare disease as an individual,…
Going through a rare disease as an individual,…
The EUROPSO podcast series focused on the Epicensus programme
At the beginning of this year, EUROPSO produced four podcast…
European Psoriasis Week 2024: Request for Complete Access to Treatment Across Europe
The European Psoriasis Week, scheduled for the last week of…
Unveiling Psoriasis: A Double Perspective
EUROPSO Podcast Episode 2
With a blend of personal narratives…
With a blend of personal narratives…
EUROPSO just launched its first podcast episode
Beyond the surface: Assessing the wellbeing of psoriatic patients
We're…
We're…
EUROPSO’s 35th Anniversary Celebration and Members Meeting: A Milestone in Psoriatic Disease Advocacy
On the eve of November 25th in Brussels, EUROPSO hosted a celebratory…
Participation of EuroPso in the EADV Pan-European Dermatology Congress
The annual conference of the European Academy of Dermatology…
Doing More than a Scratch Report
Challenging the status quo in psoriasis care through the ‘Epicensus’ programme
We at EUROPSO are delighted to be partnering with UCB Pharma…
Uniting Hope and Innovation: The IFPA Forum in Asia 2023 and Its Global Significance for Psoriatic Patients
The second International Federation of Psoriasis Associations…
Do You Have Psoriasis? Are You Thinking About Planning a Family? Talk to Your Dermatologist!
Family planning involves preparing for or preventing having…
Doing more than a scratch- Using new technologies to help people with psoriatic disease
The European Federation of Psoriasis movements - EUROPSO organised…
Study on the Quality of Life for Patients with Psoriasis in Greece
A ground-breaking project co-implemented by ‘Epidermia’
In…
In…
EUROPSO GPP Workshop 2023
This year’s first EUROPSO GPP Workshop, called “Connecting…
EUROPSO Young Round Table 2023: The importance of involving young people in advocacy and campaigning
Motivating young patients to exit their comfort zone and become…
Take control of your GPP
Source: Boehringer Ingelheim
Our long-term partner, company…
Our long-term partner, company…
Why does my psoriasis seem to get worse in winter
Fall and winter bring shorter days. Shorter days mean less sunlight…
EUROPSO General Assembly and Members Meeting
This year’s EUROPSO General Assembly and Members Meeting was…
Polka Dot Day celebrated on October 29th 2022
No person suffering from psoriasis or psoriatic arthritis should…
Welcome to our relaunched EUROPSO newsletter
It is our great pleasure to relaunch our newsletter, on this…
Uniting for Action – World Psoriasis Day, 29th October
A call to action by IPFA
Ahead of the fast-approaching World…
Ahead of the fast-approaching World…
The Psoriatic Association of Slovenia: The 1st congress for psoriatic patients was a great success
Author: Nina Pahor
The Psoriatic Association of Slovenia…
The Psoriatic Association of Slovenia…
EUROPSERVATORY Project Launch Announced for May 2023
Jan Koren, President of EUROPSO
Psoriasis has many faces…
Psoriasis has many faces…
European Psoriasis Week 2022
In 2022, the European Psoriasis Week (EPW) is dedicated…
World Psoriasis Day – Czech Republic
The Impact of Psoriatic Disease on a Woman’s Career, Family Planning, Social Life and Mental
Summary
A recent survey from IFPA, EUROPSO, and UCB interviewed…
A recent survey from IFPA, EUROPSO, and UCB interviewed…
EUROPEAN PSORIASIS WEEK #EPW
EUROPSO presents European Psoriasis Week as an annual week…
PsoProtect and PsoProtectMe Update – January 202
Dear PsoProtect supporter,
We are so grateful for your ongoing…
We are so grateful for your ongoing…
PsoProtect and PsoProtectMe Update – November 2020
Dear PsoProtect supporter,We are so grateful for your ongoing…
A Polka dot Day (Puntíkový den)
Let's put on polka dots clothes and get rid of people's…
EPIDERMIA – Greece receives an important award for the site PSORIASIMOU.GR
The Greek member of Europso, Panhellenic Society of Patients…
PsoProtectMe survey
We're asking everyone around the world with psoriasis,…
PsoProtect project
Dear EUROPSO members,
In these difficult times, I would…
In these difficult times, I would…
COVID-19: Beware of falsified medicines from unregistered websites
EMA is urging the general public not to buy medicines from unauthorized websites and other vendors aiming to exploit fears and concerns during the ongoing pandemic of coronavirus disease (COVID-19).
CORONAVIRUS COVID-19 CONCERNS?
We understand that you may have concerns about the current coronavirus known as COVID-19 ...
Booklet on EMA pre-submission and assessment processes
EMA
has published a booklet describing the journey of medicine…
has published a booklet describing the journey of medicine…
Psoriatic arthritis symptom diary
A diary for people with psoriasis to share their symptoms and
how…
how…
Psoriasis and psoriatic arthritis – the relationship you probably haven’t heard about
PsA symptom checker infographic
PSORIASIS DICTIONARY FOR PATIENTS
Your guide to help you when speaking to your doctor
Psoriasis dictionary
Sometimes it seems like doctors speak a different language. They…
IF YOU HAVE PSORIASIS ASK YOUR DERMATOLOGIST FOR CLEAR SKIN.
WHAT YOU DO WITH IT
IS UP TO YOU.
IS UP TO YOU.
Celebrating 30 years
On the occasion of our 30 anniversary, from Europso, we decided to recognise the work of our members for the last years, arranging a gala dinner where some awards were shared with them.
“Give Me My 3 Seconds” – EUROPSO
The EUROPSO Psoriasis Patient Study
Psoriasis can have a profound impact on a person’s quality of life, particularly if it is extensive, affects a visible or sensitive area, or is difficult to treat. To explore the impact of psoriasis on the quality of life of European patients and to learn about patients’ perceptions of current treatments, EUROPSO (European Federation of Psoriasis Patient Organisations) has conducted a large-scale postal survey of the members of nine European patient associations ...
OpenLetter Value of Health Cooperation
EU Health Collaboration is crucial for Europe’s future
Dear…
Dear…
EADV Cleara about Psoriasis
Patients with moderate-to-severe psoriasis do not believe clearance of their skin is a realistic treatment goal: results from the largest global psoriasis patient survey
